Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ashaparna Mondal"'
Autor:
Ashaparna Mondal, Shanooja Shanavas, Utsav Sen, Utpal Das, Nilmadhab Roy, Bipasha Bose, Priyankar Paira
Publikováno v:
RSC Advances. 12:11953-11966
To reduce the side effects of marketed cancer drugs against triple negative breast cancer cells we have reported mitochondria targeting half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes for MDA-MB-468 cell therapy and diagnosis. Out
Autor:
Ashaparna Mondal, Suban K. Sahoo, Bipasha Bose, Priyankar Paira, Utsav Sen, Venkatesan Muthukumar, Nilmadhab Roy
Publikováno v:
Dalton Transactions. 50:979-997
For diagnosing and annihilating cancer in the human body, herein, we have adopted a one pot convenient synthetic protocol to synthesize a library of half sandwich Ru(ii)-p-cymene-N^N complexes under continuous sonication and isolated their regioisome
Autor:
Ashaparna Mondal, Priyankar Paira
Publikováno v:
Dalton Transactions. 49:12865-12878
Due to the side effects of marketed cancer drugs, we designed a series of ruthenium-based fluorescent anticancer drugs, which was demonstrated to be target specific, highly cytoselective, lipophilic, water soluble, hypoxia efficient and glutathione r
Autor:
Nachimuthu Ramesh, S. K. Ashok Kumar, Anbalagan Moorthy, Shreya Ray Chaudhuri, Priyankar Paira, Sourav De, Ashaparna Mondal, Arpita Panda, R. Selva Kumar, Subhasis Banerjee, Prasanth Manohar, Gajanan Rahosaheb Jadhav
Publikováno v:
New Journal of Chemistry. 43:3291-3302
In this article, Ru(II)–arene-2-pyridinylbenzoxazole complexes [(η6-p-cymene)RuCl(κ2-N,N-5-bromo-2-(pyridine-2-yl)benzo[d]oxazole)] (4) and [(η6-benzene)RuCl(κ2-N,N-5-bromo-2-(pyridine-2-yl)benzo[d]oxazole)] (5) and Ru(II)–arene-2-quinolylben
Autor:
Ashaparna, Mondal, Utsav, Sen, Nilmadhab, Roy, Venkatesan, Muthukumar, Suban Kumar, Sahoo, Bipasha, Bose, Priyankar, Paira
Publikováno v:
Dalton transactions (Cambridge, England : 2003). 50(3)
For diagnosing and annihilating cancer in the human body, herein, we have adopted a one pot convenient synthetic protocol to synthesize a library of half sandwich Ru(ii)-p-cymene-N^N complexes under continuous sonication and isolated their regioisome
Autor:
Ashaparna, Mondal, Priyankar, Paira
Publikováno v:
Dalton transactions (Cambridge, England : 2003). 49(36)
Due to the side effects of marketed cancer drugs, we designed a series of ruthenium-based fluorescent anticancer drugs, which was demonstrated to be target specific, highly cytoselective, lipophilic, water soluble, hypoxia efficient and glutathione r
Publikováno v:
LEGUME RESEARCH - AN INTERNATIONAL JOURNAL.
The experiment comprising of four levels of phosphorus, i.e., 0, 20, 40 and 60 kg ha-1 and four levels of zinc, i.e., 0, 5, 10 and 15 kg ha-1 was conducted to investigate the interaction effect of phosphorus and zinc fertilization on yield and yield
Autor:
Ashaparna Mondal, Priyankar Paira
Publikováno v:
Current Organic Synthesis. 15:179-207
Background: Currently ruthenium complexes are immerging as effective anticancer agents due to their less toxicity, better antiproliferative and antimetastatic activity, better stability in cellular environment and most importantly variable oxidation
Publikováno v:
ChemistrySelect. 2:2480-2486
We have introduced Amberlite IRA 402(OH) mediated green synthesis of benzothiazolyl quinoline based fluorescent scaffolds (6a–l) for cancer theranostic application. Compounds 6 b (8-[2-(2-benzothiazol-2-yl-phenoxy)-ethoxy]-5,7-dibromoquinoline),6 d
Autor:
Yung-Chih Kuo, Ashaparna Mondal, Bidisha Sarkar, Yukti Madaan, Anbalagan Moorthy, Priyankar Paira, Nilmadhab Roy
Publikováno v:
Dalton transactions (Cambridge, England : 2003). 48(32)
Of late, cancer has become a terrible disease affecting people throughout the world. Keeping this in mind, we tried to design drugs that are more lipophilic, target-specific, water-soluble, cytoselective and fluorescent. In this regard, we reported n